+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Pharming Group NV - logo

The Pharming Group offers novel platforms for the production of protein therapeutics, as well as processes for the purification and formulation. The company’s best known product is Ruconest, a human C1 inhibitor. Human C1 inhibitor is a protein involved in the regulation of the complement and contact pathways of the immune system. Pharming Group N.V. is headquartered in Leiden, the Netherlands.

Fabry's Disease Pipeline Analysis 2019 (H1) - Product Thumbnail Image

Fabry's Disease Pipeline Analysis 2019 (H1)

  • Report
  • May 2019
  • 105 Pages
  • Global
From
Ischemia Reperfusion Injury - Pipeline Review, H2 2020 - Product Thumbnail Image

Ischemia Reperfusion Injury - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 197 Pages
  • Global
From
Hypertension - Pipeline Review, H1 2020 - Product Thumbnail Image

Hypertension - Pipeline Review, H1 2020

  • Drug Pipelines
  • June 2020
  • 772 Pages
  • Global
From
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Global Clinical Trials Review, H2, 2021 - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) - Global Clinical Trials Review, H2, 2021

  • Clinical Trials
  • October 2021
  • 127 Pages
  • Global
From
Pompe Disease - Pipeline Review, H2 2020 - Product Thumbnail Image

Pompe Disease - Pipeline Review, H2 2020

  • Drug Pipelines
  • October 2020
  • 104 Pages
  • Global
From
Fabry Disease - Pipeline Review, H2 2020 - Product Thumbnail Image

Fabry Disease - Pipeline Review, H2 2020

  • Drug Pipelines
  • August 2020
  • 126 Pages
  • Global
From
Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Disease - Global Clinical Trials Review, H2 2020 - Product Thumbnail Image

Hereditary Angioedema (HAE) (C1 Esterase Inhibitor [C1-INH] Deficiency) Disease - Global Clinical Trials Review, H2 2020

  • Clinical Trials
  • October 2020
  • 123 Pages
  • Global
From
Lysosomal Alpha Glucosidase - Pipeline Review, H2 2020 - Product Thumbnail Image

Lysosomal Alpha Glucosidase - Pipeline Review, H2 2020

  • Drug Pipelines
  • July 2020
  • 76 Pages
  • Global
From
Pharming Group N.V. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis - Product Thumbnail Image

Pharming Group N.V. Fundamental Company Report Including Financial, SWOT, Competitors and Industry Analysis

  • Company Profile
  • May 2024
  • 50 Pages
From
Pharming Group NV (PHARM) - Financial and Strategic SWOT Analysis Review - Product Thumbnail Image

Pharming Group NV (PHARM) - Financial and Strategic SWOT Analysis Review

  • SWOT Analysis
  • May 2023
  • 53 Pages
From
Loading Indicator